Biomarker test could cut unnecessary antifungal drugs in ICU
NCT ID NCT02154178
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 20 times
Summary
This study looked at whether using special tests (biomarkers) for fungal infections could help doctors safely stop antifungal medicines earlier in intensive care patients. The goal was to reduce the number of days patients receive these drugs, which can have side effects. The study involved 110 adults in the ICU who needed antifungal treatment for the first time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, 59035, France
Conditions
Explore the condition pages connected to this study.